Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress

Wugen, Inc. presented data for its two lead programs, WU-CART-007 and WU-NK-101, in separate presentations at the European Hematology Association 2023 Congress, taking place from June 8 – 11, 2023 in Frankfurt, Germany.